(Q28077394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

peritoneal carcinomatosis

30 March 2020

main subject

chemotherapy

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Rahul Rajeev

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

language of work or name

1 reference

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

23

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

36-46

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27009455%20AND%20SRC:MED&resulttype=core&format=json

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

30 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Surgical management of bowel obstruction in patients with peritoneal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

21 January 2018

Peritonectomy procedures

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Diffusion-weighted Imaging of Peritoneal Disease for Noninvasive Staging of Advanced Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Anaesthesia for intra-peritoneal perfusion of hyperthermic chemotherapy. Haemodynamic changes, oxygen consumption and delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Toxicity of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients with sarcomatosis/carcinomatosis: early experience and phase 1 results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Extensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Pharmacokinetics of intraperitoneal mitomycin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Mitomycin C Pharmacokinetics as Predictor of Severe Neutropenia in Hyperthermic Intraperitoneal Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107

Peritoneal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481602300107